SLC35A3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.363800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.095400E-01
Normal-vs-Stage2
1.923370E-01
Normal-vs-Stage3
8.895400E-01
Normal-vs-Stage4
9.057700E-02
Stage1-vs-Stage2
8.290400E-01
Stage1-vs-Stage3
2.351000E-01
Stage1-vs-Stage4
3.685600E-01
Stage2-vs-Stage3
1.502570E-01
Stage2-vs-Stage4
6.342400E-02
Stage3-vs-Stage4
9.830200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.563600E-01
Normal-vs-AfricanAmerican
1.975980E-01
Normal-vs-Asian
2.656400E-01
Caucasian-vs-AfricanAmerican
5.070200E-01
Caucasian-vs-Asian
7.991400E-01
AfricanAmerican-vs-Asian
4.616200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.923010E-01
Normal-vs-Female
2.960000E-01
Male-vs-Female
9.170400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.291000E-01
Normal-vs-Age(41-60Yrs)
1.405330E-04
Normal-vs-Age(61-80Yrs)
2.327000E-01
Normal-vs-Age(81-100Yrs)
4.270000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.657200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.953800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.579800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.079500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.902200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.869800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.235600E-01
Normal-vs-Daily Drinker
3.437200E-01
Normal-vs-Weekly Drinker
5.883800E-01
Normal-vs-Occasional Drinker
1.093850E-01
Normal-vs-Social Drinker
1.508160E-01
Non Drinker-vs-Daily Drinker
8.116000E-01
Non Drinker-vs-Weekly Drinker
3.325200E-01
Non Drinker-vs-Occasional Drinker
1.349190E-01
Non Drinker-vs-Social Drinker
3.311000E-01
Daily Drinker-vs-Weekly Drinker
3.646400E-01
Daily Drinker-vs-Occasional Drinker
3.325000E-01
Daily Drinker-vs-Social Drinker
5.763800E-01
Weekly Drinker-vs-Occasional Drinker
6.222000E-02
Weekly Drinker-vs-Social Drinker
1.390830E-01
Occasional Drinker-vs-Social Drinker
6.962800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.383500E-02
Normal-vs-Grade 2
3.941500E-02
Normal-vs-Grade 3
1.276290E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.319800E-02
Grade 1-vs-Grade 3
4.583200E-03
Grade 1-vs-Grade 4
9.383500E-02
Grade 2-vs-Grade 3
7.482600E-01
Grade 2-vs-Grade 4
3.941500E-02
Grade 3-vs-Grade 4
1.276290E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.374800E-01
Normal-vs-NonDiabetic
2.203200E-01
Diabetic-vs-NonDiabetic
4.111800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.873800E-01
Normal-vs-NoPancreatitis
2.420400E-01
Pancreatitis-vs-NoPancreatitis
6.687600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.804500E-03
Normal-vs-N1
1.557000E-01
N0-vs-N1
8.061600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.223500E-04
Normal-vs-TP53-NonMutant
2.417800E-03
TP53-Mutant-vs-TP53-NonMutant
3.788400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
